FOXM1 and pachyonychia congenita: Taken together, this PC-specific analysis indicates that biological aging genes in PC offer independent predictive evidence compared to known markers of PC progression, especially for patients with higher Gleason scores, and could be effectively utilized alongside FOXM1 for patients of younger age for enhanced predictions of PC progression.